» Articles » PMID: 25659767

Elevated SP/NK-1R in Esophageal Carcinoma Promotes Esophageal Carcinoma Cell Proliferation and Migration

Overview
Journal Gene
Specialty Molecular Biology
Date 2015 Feb 10
PMID 25659767
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Esophageal squamous cell carcinoma (ESCC) remains one of the most lethal malignant tumors, and currently there is no effective ways to manage the late stage disease. Therefore clarifying the mechanisms underlying the development of ESCC is of great importance to develop novel therapeutic agents. The present study focuses on the interaction between neurotransmitter substance P (SP) together with its receptor NK-1R and ESCC progression.

Methods: The distribution of SP positive nerve fibers and expression of NK-1R were detected in ESCC tissue using immunohistochemistry. The effects of SP stimulation and blocking on the growth and migration of ESCC cells were measured by in vitro and in vivo assay.

Results: A higher density of SP positive nerve fibers and elevated NK-1R expression on ESCC cells were observed. More importantly, the SP positive fiber density was correlated with tumor size and lymph node metastasis. SP promoted ESCC cell proliferation and migration by modulation of intracellular calcium levels.

Conclusion: NK-1R activation by SP stimulation promotes growth and migration of ESCC cells.

Citing Articles

From pain to tumor immunity: influence of peripheral sensory neurons in cancer.

Mardelle U, Bretaud N, Daher C, Feuillet V Front Immunol. 2024; 15:1335387.

PMID: 38433844 PMC: 10905387. DOI: 10.3389/fimmu.2024.1335387.


Advances in the research and application of neurokinin-1 receptor antagonists.

Hong X, Ma J, Zheng S, Zhao G, Fu C J Zhejiang Univ Sci B. 2024; 25(2):91-105.

PMID: 38303494 PMC: 10835208. DOI: 10.1631/jzus.B2300455.


The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant.

Covenas R, Rodriguez F, Robinson P, Munoz M Int J Mol Sci. 2023; 24(21).

PMID: 37958914 PMC: 10650658. DOI: 10.3390/ijms242115936.


Multimodal roles of transient receptor potential channel activation in inducing pathological tissue scarification.

Zheng Y, Huang Q, Zhang Y, Geng L, Wang W, Zhang H Front Immunol. 2023; 14:1237992.

PMID: 37705977 PMC: 10497121. DOI: 10.3389/fimmu.2023.1237992.


Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation.

Cao X, Yang Y, Zhou W, Wang Y, Wang X, Ge X BMC Cancer. 2023; 23(1):471.

PMID: 37221457 PMC: 10204192. DOI: 10.1186/s12885-023-10954-8.